Platinum Based Cancer Drug Market Report

Global and Region Platinum Based Cancer Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：171
  • REPORT CODE：GMM1010280
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

    Asia-Pacific is the largest sales place, with a sales market share nearly 42% in 2019. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 20%.

    The report details the trend, potential and market size of Platinum Based Cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Platinum Based Cancer Drugmarket, defines the market attractiveness level of Platinum Based Cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Platinum Based Cancer Drug industry, describes the types of Platinum Based Cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Platinum Based Cancer Drug market and the development prospects and opportunities of Platinum Based Cancer Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Platinum Based Cancer Drug market in Chapter 13.

    By Player:

    • Novartis

    • Teva

    • Sun Pharma

    • Hengrui Medicine

    • Yi Bai Pharmaceutical

    • ASK Pharma

    • Qilu Pharmaceutical

    • Debiopharm

    • Mylan

    • SK Chemicals

    • Sanofi

    • Accord Healthcare

    • Dr Reddy's Laboratories

    • Pfizer

    By Type:

    • Cisplatin

    • Oxaliplatin

    • Carboplatin

    • Other

    By End-User:

    • Colorectal Cancer

    • Ovarian Cancer

    • Lung Cancer

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Platinum Based Cancer Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Platinum Based Cancer Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Platinum Based Cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Platinum Based Cancer Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Platinum Based Cancer Drug Market Analysis and Outlook to 2022

    • 7.1 Global Platinum Based Cancer Drug Consumption (2017-2022)

    • 7.2 United States Platinum Based Cancer Drug Consumption (2017-2022)

    • 7.3 Europe Platinum Based Cancer Drug Consumption (2017-2022)

    • 7.4 China Platinum Based Cancer Drug Consumption (2017-2022)

    • 7.5 Japan Platinum Based Cancer Drug Consumption (2017-2022)

    • 7.6 India Platinum Based Cancer Drug Consumption (2017-2022)

    • 7.7 South Korea Platinum Based Cancer Drug Consumption (2017-2022)

    8 Region and Country-wise Platinum Based Cancer Drug Market Analysis and Outlook to 2028

    • 8.1 Global Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    • 8.2 United States Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    • 8.4 China Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    • 8.6 India Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Platinum Based Cancer Drug Consumption Forecast (2022-2028)

    9 Global Platinum Based Cancer Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Platinum Based Cancer Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cisplatin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oxaliplatin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Carboplatin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Platinum Based Cancer Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Platinum Based Cancer Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Platinum Based Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cisplatin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oxaliplatin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Carboplatin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Platinum Based Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Platinum Based Cancer Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Platinum Based Cancer Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Platinum Based Cancer Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Platinum Based Cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Platinum Based Cancer Drug Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Platinum Based Cancer Drug Product and Service

    • 14.2 Teva

      • 14.2.1 Teva Company Details

      • 14.2.2 Teva Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Teva Platinum Based Cancer Drug Product and Service

    • 14.3 Sun Pharma

      • 14.3.1 Sun Pharma Company Details

      • 14.3.2 Sun Pharma Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sun Pharma Platinum Based Cancer Drug Product and Service

    • 14.4 Hengrui Medicine

      • 14.4.1 Hengrui Medicine Company Details

      • 14.4.2 Hengrui Medicine Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hengrui Medicine Platinum Based Cancer Drug Product and Service

    • 14.5 Yi Bai Pharmaceutical

      • 14.5.1 Yi Bai Pharmaceutical Company Details

      • 14.5.2 Yi Bai Pharmaceutical Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Yi Bai Pharmaceutical Platinum Based Cancer Drug Product and Service

    • 14.6 ASK Pharma

      • 14.6.1 ASK Pharma Company Details

      • 14.6.2 ASK Pharma Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 ASK Pharma Platinum Based Cancer Drug Product and Service

    • 14.7 Qilu Pharmaceutical

      • 14.7.1 Qilu Pharmaceutical Company Details

      • 14.7.2 Qilu Pharmaceutical Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Qilu Pharmaceutical Platinum Based Cancer Drug Product and Service

    • 14.8 Debiopharm

      • 14.8.1 Debiopharm Company Details

      • 14.8.2 Debiopharm Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Debiopharm Platinum Based Cancer Drug Product and Service

    • 14.9 Mylan

      • 14.9.1 Mylan Company Details

      • 14.9.2 Mylan Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Mylan Platinum Based Cancer Drug Product and Service

    • 14.10 SK Chemicals

      • 14.10.1 SK Chemicals Company Details

      • 14.10.2 SK Chemicals Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 SK Chemicals Platinum Based Cancer Drug Product and Service

    • 14.11 Sanofi

      • 14.11.1 Sanofi Company Details

      • 14.11.2 Sanofi Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Sanofi Platinum Based Cancer Drug Product and Service

    • 14.12 Accord Healthcare

      • 14.12.1 Accord Healthcare Company Details

      • 14.12.2 Accord Healthcare Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Accord Healthcare Platinum Based Cancer Drug Product and Service

    • 14.13 Dr Reddy's Laboratories

      • 14.13.1 Dr Reddy's Laboratories Company Details

      • 14.13.2 Dr Reddy's Laboratories Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Dr Reddy's Laboratories Platinum Based Cancer Drug Product and Service

    • 14.14 Pfizer

      • 14.14.1 Pfizer Company Details

      • 14.14.2 Pfizer Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Pfizer Platinum Based Cancer Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Platinum Based Cancer Drug

    • Figure Platinum Based Cancer Drug Picture

    • Table Global Platinum Based Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Platinum Based Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Platinum Based Cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Platinum Based Cancer Drug Consumption by Country (2017-2022)

    • Figure United States Platinum Based Cancer Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Platinum Based Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure China Platinum Based Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Platinum Based Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure India Platinum Based Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Platinum Based Cancer Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Platinum Based Cancer Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Platinum Based Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Platinum Based Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Platinum Based Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Platinum Based Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Platinum Based Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Platinum Based Cancer Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cisplatin Consumption and Growth Rate (2017-2022)

    • Figure Global Oxaliplatin Consumption and Growth Rate (2017-2022)

    • Figure Global Carboplatin Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Cisplatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oxaliplatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Carboplatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Platinum Based Cancer Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Platinum Based Cancer Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Platinum Based Cancer Drug Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Platinum Based Cancer Drug Product and Service

    • Table Sun Pharma (Foundation Year, Company Profile and etc.)

    • Table Sun Pharma Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Platinum Based Cancer Drug Product and Service

    • Table Hengrui Medicine (Foundation Year, Company Profile and etc.)

    • Table Hengrui Medicine Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hengrui Medicine Platinum Based Cancer Drug Product and Service

    • Table Yi Bai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Yi Bai Pharmaceutical Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yi Bai Pharmaceutical Platinum Based Cancer Drug Product and Service

    • Table ASK Pharma (Foundation Year, Company Profile and etc.)

    • Table ASK Pharma Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ASK Pharma Platinum Based Cancer Drug Product and Service

    • Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Qilu Pharmaceutical Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Platinum Based Cancer Drug Product and Service

    • Table Debiopharm (Foundation Year, Company Profile and etc.)

    • Table Debiopharm Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Debiopharm Platinum Based Cancer Drug Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Platinum Based Cancer Drug Product and Service

    • Table SK Chemicals (Foundation Year, Company Profile and etc.)

    • Table SK Chemicals Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table SK Chemicals Platinum Based Cancer Drug Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Platinum Based Cancer Drug Product and Service

    • Table Accord Healthcare (Foundation Year, Company Profile and etc.)

    • Table Accord Healthcare Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accord Healthcare Platinum Based Cancer Drug Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Platinum Based Cancer Drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Platinum Based Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Platinum Based Cancer Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US